Cervical cancer prevention in El Salvador (CAPE)-An HPV testing-based demonstration project: Changing the secondary prevention paradigm in a lower middle-income country

Mauricio Maza; Karla Alfaro; Jillian Garai; Mario Morales Velado; Julia C Gage; Philip E Castle; Juan Felix; Silvana Luciani; Nicole Campos; Jane Kim; Rachel Masch; Miriam Cremer

doi:10.1016/j.gore.2017.02.011

Cervical cancer prevention in El Salvador (CAPE)-An HPV testing-based demonstration project: Changing the secondary prevention paradigm in a lower middle-income country

Gynecol Oncol Rep. 2017 Mar 3:20:58-61. doi: 10.1016/j.gore.2017.02.011. eCollection 2017 May.

Authors

Affiliations

¹ Basic Health International, Colonia San Francisco, Avenida Las Camelias #14, San Salvador, El Salvador.
² Basic Health International, 25 Broadway, 5th Floor, New York, NY, USA.
³ National Unit of Control and Prevention of Cancer, Ministry of Health, San Salvador, El Salvador.
⁴ Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Dr., Rockville, MD, USA.
⁵ Albert Einstein College of Medicine, 1300 Morris Park Ave., Bronx, NY, USA.
⁶ Department of Pathology, University of Southern California, 2011 Zonal Ave., Los Angeles, CA, USA.
⁷ Department of Noncommunicable Diseases and Mental Health, Pan American Health Organization, 525 23rd St., NW, Washington, DC, USA.
⁸ Center for Health Decision Science, Harvard School of Public Health, 718 Huntington Ave., Boston, MA, USA.
⁹ Icahn School of Medicine at Mount Sinai, One Gustav Levy Pl., New York, NY, USA.

Abstract

•CareHPV tests were used to compare screen-and-treat and colposcopy management.•Screen-and-treat strategy with HPV testing was found to be very cost-effective.•CAPE has screened > 25,000 women in the Paracentral region.•Over 70% of screen-positive women received recommended treatment within six months.•CAPE is an example of public-private partnership resulting in paradigm change.

Keywords: Cervical cancer; HPV; Implementation; Screen-and-treat; Screening.